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HSP70i Accelerates Depigmentation in a Mouse
Model of Autoimmune Vitiligo
Cecele J. Denman1, James McCracken2, Vidhya Hariharan1, Jared Klarquist1, Kepa Oyarbide-Valencia1,
Jose´ A. Guevara-Patin˜o2 and I. Caroline Le Poole1
Vitiligo is a T-cell-mediated autoimmune disease of the skin. Progressive depigmentation accelerates in
response to stress. Personal trauma, contact with bleaching phenols, overexposure to UV, and mechanical injury
can lead to progressive loss of melanocytes. This study was focused on the role of stress protein heat shock
protein (HSP)70 for translating stress into an autoimmune disease to melanocytes. Intracellular HSP70 can act as
a cytoprotectant, preventing apoptosis in cells under stress. Isoform HSP70i can be secreted by live cells, and in
prior in vitro studies, HSP70 has been shown to activate dendritic cells and elicit an immune response to
chaperoned proteins and peptides. Here, the role of HSP70 in precipitating and perpetuating vitiligo was
assessed in vivo in a mouse model of autoimmune vitiligo. In this model, depigmentation was introduced by
gene gun vaccination with eukaryotic expression plasmids encoding melanocyte differentiation antigens.
Inclusion of human and mouse-derived inducible HSP70 in the vaccination protocol significantly increased and
accelerated depigmentation in this model, accompanied by the induction of prolonged humoral responses to
HSP70. Cytotoxicity toward targets loaded with a K(b)-restricted tyrosinase-related protein 2-derived peptide
correlated with depigmentation. The data presented strongly support a role for HSP70i in progressive
depigmentation in vivo.
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INTRODUCTION
Vitiligo patients present with progressive depigmentation
involving progressive loss of melanocytes from the skin (Le
Poole et al., 1993a). Loss of melanocytes within hair follicles
has also been reported, and premature graying as well as
hair loss appear to mechanistically associate with vitiligo
(Hedstrand et al., 2006).
The process of depigmentation is associated with a T-cell-
mediated immune response to melanocytes during disease
progression (Ogg et al., 1998). This etiological factor was
long overlooked, as T-cell infiltrates are not observed in
stable disease and immune infiltrates are restricted to a
narrow margin of skin coinciding with the disappearance of
melanocytes (Das et al., 2001).
In vitiligo, a wide array of stress factors can provoke an
autoimmune response to melanocytes. Precipitating factors in
vitiligo include overexposure to UV (sunlight) during a sunny
vacation, and contact with bleaching phenols, including
4-tertiary butyl phenol (4-TBP) in the home or workplace, as
in occupational vitiligo (Boissy and Manga, 2004; Namazi,
2007). Emotional stress is similarly reported as a precipitating
factor by patients, including death of first-degree relatives and
childbirth (Barisic´-Drusko and Rucevic´, 2004). Mechanical
injury after cuts and burns can induce new lesions, and
50% of patients report observing Koebner’s phenomenon
at the sites of minor scrapes, cuts, and burns to the skin
(unpublished observation).
A hereditary component to vitiligo is evident from the
observation that only 0.5–1% of individuals will develop
progressive depigmentation of the skin in response to stress
(Spritz, 2007). Only a subset of individuals will develop
vitiligo in response to stress, suggesting the involvement of a
hereditary component.
It has not yet been elucidated how exposure to stress in
individuals with a genetic propensity to develop vitiligo
translates into an autoimmune disease targeting melanocytes
within the skin. In vitro studies have implicated heat shock
protein (HSP)70 as a precipitating factor in vitiligo. Specifi-
cally, melanocytes overexpress HSP70 in response to
bleaching phenol 4-TBP (Kroll et al., 2005). Increased
amounts of HSP70 were detectable in the supernatant of
vitiligo compared to control melanocytes (Kroll et al., 2005).
Exposure to 4-TBP sensitized melanocytes to dendritic cells
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(DC)-mediated cytotoxicity, mediated at least, in part, by
enhanced expression of tumor necrosis factor-related apop-
tosis inducing ligand (TRAIL) by HSP70-exposed DCs and
elevated expression of TRAIL receptor 1 and TRAIL receptor
2 by melanocytes. HSP70 enhances antigen uptake and
processing by DC, activating DC, and stimulating T-cell-
mediated immune responses (Haug et al., 2005; Bendz et al.,
2007; Pido-Lopez et al., 2007). Consistent differential
expression of HSP70 between non-lesional and lesional skin
of three vitiligo patients as observed by immunohistology
infers a role for HSP70 in depigmentation (Le Poole and
Luiten, 2008), and the stress protein has been implicated in
autoimmune responses per se by others (Multhoff, 2006).
HSP70 is one of several stress proteins upregulated in
response to heat shock (Bivik et al., 2007). Under stress, cell
shut down overall protein synthesis while maintaining stress
protein expression. HSPs will chaperone proteins to protect
the cell from undergoing apoptosis until the stressful episode
has passed (Bivik et al., 2007). HSPs chaperoning proteins
and peptides from dying cells can thus induce an immune
response to cells from which they were derived.
The stress protein HSP70 is unique in the respect that it
was shown to be secreted by live cells (Mambula et al.,
2007). Whereas the process of HSP70 secretion remains
poorly understood, it appears to involve exosome formation
by tumor cells (Gastpar et al., 2005). Secretion was first
reported for neuronal cells, understandable from the stand-
point of synaptic vesicles projected into the extracellular
under normal physiologic conditions. Melanocytes may
similarly secrete HSP70 containing melanosomes under
stress. This is particularly credible because HSP70 secretion
is associated with lysosomes (Mambula and Calderwood,
2006). Intracellular HSP70i (inducible HSP70) translocates to
lysosomes and lysosomes are highly congruent with melano-
somes, suggesting that HSP70 can localize to melanosomes
as well (Le Poole et al., 1993b). As melanosome export is a
process important to skin pigmentation, export of HSP70
chaperoning peptides and proteins from the melanosomal
compartment can likely contribute to the immunogenicity of
melanocyte differentiation antigens homing to the melano-
somal organelle.
Under standard physiologic conditions, constitutive
HSP70 isoforms are expressed within the cell offering
cytoprotection to the cell. A total of 11 genes have been
identified coding for HSP70 isoforms with a high degree of
homology (Tavaria et al., 1996), sharing molecular properties
including an approximate molecular weight of 70 kDa and an
N-terminal peptide binding domain regulated by a C-terminal
ATPase domain. When released into the extracellular milieu
through cell death or active secretion, HSP70 interacts with
DC to enhance uptake of antigens. HSP70 induces DC
maturation, and the term ‘chaperokine’ has been coined to
describe its role in immune stimulation (Asea, 2006). These
properties render HSP70 an ideal vaccine adjuvant for
antitumor treatment, stimulating immune reactivity to the
cells from which they are derived. Clinical trials for tumor-
derived HSP-based vaccines are underway (Trimble et al.,
2003).
Following experimental evidence suggesting for a role of
HSP70 in depigmentation in vitro, the challenge has been to
develop a reproducible in vivo mouse model of autoimmune
vitiligo. The current model makes use of vaccination
strategies otherwise used to test therapeutic efficacy against
melanoma tumors. It has been observed that progressive
depigmentation of the pelage can be achieved by gene gun
vaccination with DNA encoding melanocyte differentiation
antigens, which is the premise on which the current model is
built (Overwijk et al., 1999).
Human TRP-2, as well as human and mouse-derived
HSP70i were cloned into eukaryotic expression vectors. It
should be noted that TRP-2 serves as a model antigen,
whereas several other melanocyte differentiation antigens
can similarly be included in the vaccine to develop a
functional model of autoimmune vitiligo. Xenogeneity of
melanocyte differentiation antigens has been shown to
contribute to their immunogenicity (Engelhorn et al., 2006).
Mice were gene gun vaccinated and depigmentation was
scored by scanning anesthetized mice. Relevant observations
regarding the extent of depigmentation were correlated with
the assessment of the humoral and cellular responses to
vaccine components. The in vivo observations in this mouse
model are important for establishing a potential role for
HSP70 in precipitating and expansion of progressive auto-
immune vitiligo.
RESULTS
Depigmentation in response to gene gun vaccination
In Figure 1a, depigmentation is shown in 129S7 agouti mice
that were gene gun vaccinated in the flank (ventral coloration
is off-white to yellow in this mouse strain). Groups of five
mice are shown, each representing 10 mice vaccinated with
either empty vector control plasmid, a plasmid encoding
human HSP70 (hHSP70), a plasmid encoding hTRP-2, or a
combination of HSP70 and TRP-2-encoding plasmids. All
groups were vaccinated with the same total amount of DNA.
The only group of mice that displayed visible depigmentation
in this experiment was the group vaccinated with a
combination of hTRP-2 and hHSP70. Six weeks after the
final vaccination, depigmentation in this group was signifi-
cantly increased at Po0.05 compared with mice vaccinated
with control vector DNA (P¼0.03) or from mice vaccinated
with hTRP-2 alone (P¼ 0.04). In Figure 1b, data are shown
for C57BL/6 mice vaccinated with the same plasmids in the
ventral region. These data were consistent with those
observed for 129S7 mice. Whereas some depigmentation
was observed in response to hTRP-2 alone 1 month after the
final vaccination, significant and persistent depigmentation
was observed only in the mice vaccinated with a combina-
tion of hTRP-2 and hHSP70 plasmids.
Comparing the depigmenting effects of hHSP70 versus mHSP70
In Figure 2a, results are shown for C57BL/6 mice that were
vaccinated with the same plasmids as those included in
Figure 1, as well as with mouse-derived mhsp70A1A-
encoding plasmid alone or in combination with hTRP-2
encoding DNA, all at the same final DNA concentrations.
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In this figure, it can be observed that both mouse- and
human-derived HSP70 accelerate autoimmune depigmenta-
tion to the same extent. No significant difference was
detected among groups vaccinated with hTRP-2 combined
with either hHSP70i or mhsp70A1A 6 weeks after the final
vaccination. In Figure 2b, data are shown for dorsal
depigmentation, followed away from the original vaccination
site in C57BL/6 mice. Mouse scans (insets) illustrate the data
represented in the graph, with significant dorsal depigmenta-
tion observed only in mice vaccinated with a combination of
hTRP-2 and mhsp70-encoding plasmids.
Immunohistology of depigmented skin
Figure 3 depicts the skin of depigmented (hTRP-2 and
hHSP70 vaccinated) versus normally pigmented (control
vector vaccinated) mice. Immunohistology of frozen skin
sections was performed to detect the presence and location of
melanocytes and T cells. TRP-2 and CD3e immunostaining
was highlighted by arrows in samples of control vector-
vaccinated skin. It was consistently observed that melano-
cytes were absent from follicles of depigmented hair. T cells
that were easily detectable in skin surrounding pigmented
hair follicles, and abundant within mouse epidermis of
control vector-vaccinated skin samples, were virtually absent
from skin with depigmented hair.
Humoral responses to gene gun vaccination
In Figure 4, blots probed with sera from mice vaccinated with
hTRP-2 (a), control vector (b), or hHSP70 alone (c), or a
combination of hHSP70 and hTRP-2 (d) versus a combination
of mHSP70 and hTRP-2 (e) are shown to illustrate a
prominent band observed with a molecular weight of
approximately 70 kDa exclusively in mice vaccinated with
(a combination of) expression vectors that encode HSP70 as
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Figure 1. hHSP70 accelerates depigmentation in 2 different mouse strains. (a) HSP70 induces depigmentation in 129S7 agouti mice. Ten mice per group
received 4 weekly vaccinations to the flank to avoid the off-white/yellow ventral region of this mouse strain, where depigmentation is difficult to appreciate.
Vaccinations consisted of 4.8 mg DNA delivered by biolistic gene gun, containing combinations of expression plasmids encoding hTRP-2 and/or hHSP70, or
empty vector control DNA. Images were prepared 6 weeks after the final vaccination. (b) Depigmentation is accelerated in response to HSP70. C57BL/6 mice
(10 per group) were gene gun vaccinated weekly with 4.8 mg plasmid DNA encoding hTRP-2 and/or hHSP70, or empty vector control plasmid by biolistic gene
gun vaccination to evaluate depigmentation in response to HSP70 in a mouse strain different from 129S7 shown in panel (a). Ventral depigmentation was
quantified starting 1 month after vaccination.
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shown in panels c–e. Conversely, mice vaccinated with TRP-
2 or empty vector (a, b) DNA alone did not mount a
prominent humoral response to a 70 kDa protein. A lack of
humoral responses to TRP-2 after vaccination with any of the
genes included in our vaccine strategies, including hHSP70,
mHSP70, or TRP-2, was illustrated by a lack of reactivity with
TRP-2-transfected COS cells in Figure 4c and e. Finally, in
Figure 4f, the recognized 70 kDa band was identified as
HSP70, loaded as a purified protein versus an equal amount
of HSP60 in the adjacent lane.
Cytotoxicity to a major histocompatibility complex class I
restricted, TRP-2-derived peptide
Figure 5 illustrates reactivity to a K(b)-restricted, TRP-2-
derived peptide major histocompatibility complex class I-
restricted peptide (peak P7) to illustrate cytotoxic T-cell
responses to melanocytes induced by vaccines containing a
combination of HSP70 and TRP-2-encoding plasmids.
Cytotoxicity amounting to 30.1% lysis in this group was
observed toward spleen cells loaded with a TRP-2-derived
peptide within 18 hours (Figure 5b). Such reactivity was not
observed in mice vaccinated with HSP70 alone (Figure 5b).
For these experiments, mice were re-vaccinated once 5 days
before a challenge with labeled and loaded spleen cells from
syngeneic mice.
DISCUSSION
Gene gun vaccination has proven a successful means of
introducing antitumor vaccines into mice to assess their
efficacy in preventing or treating tumor outgrowth
(Lauterbach et al., 2006). In particular, this mode of vaccine
administration has been used to demonstrate efficacy of
vaccines to treat melanoma (Steitz et al., 2000). DNA-based
vaccination against differentiation antigen TRP-2 was shown
to induce measurable antitumor responses when using
human-derived sequences. When administering antimelano-
ma vaccines, reduced tumor growth was found to be
associated with pelage depigmentation in mice, reminiscent
of leucoderma observed in melanoma patients developing
immune responses to their tumor. Indeed, leucoderma is
considered a positive prognostic factor among melanoma
patients (Nordlund et al., 1983). An important observation
has been the development of pelage depigmentation in the
absence of tumor involvement among vaccinated mice
(Nordlund et al., 1983). It has since been observed that
stress introduced by a needle prick can precipitate depig-
menting lesions in TRP-2-vaccinated mice (Lane et al., 2004).
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Figure 2. Progressive depigmentation induced by mHSP70 involves areas
not exposed to stress. (a) mHSP70 similarly contributes to accelerated
depigmentation in mice. Groups of 10 C57BL/6 mice were gene gun
vaccinated weekly with 4.8 mg DNA consisting of (combinations of)
expression plasmids encoding TRP-2 and/or HSP70, or no inset. HSP70 was
either of human or mouse origin. Ventral depigmentation as shown was
measured 3 weeks after the final vaccination. The data demonstrate that
accelerated depigmentation by hHSP70 cannot be ascribed to its
xenogeneity. (b) Dorsal depigmentation in C57BL/6 mice vaccinated in the
ventral region. Mice were vaccinated as indicated in panel (a). Dorsal scans
taken 8 weeks after the final vaccination are shown. Insets: example mice
vaccinated weekly for 4 weeks with 2.4 mg DNA encoding human HSP70 and
2.4mg empty control vector (left) or 2.4 mg mouse hsp70-encoding DNA
combined with 2.4 mg human TRP-2 encoding DNA (right), showing dorsal
depigmentation only in the latter group.
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Pigmented CD3 Depigmented CD3
Figure 3. Gradual depigmentation of the pelage is associated with loss of
melanocytes and T cells from the skin. TRP-2 and CD3e immunostaining
shown in cryosections from representative biopsy of ventral skin vaccinated
with control plasmid (TRP-2 pigmented, CD3 pigmented) and a combination
of TRP-2 and hHSP70-encoding plasmids (TRP-2 depigmented, CD3
depigmented). Arrows indicate melanocytes as detected by Abs to TRP-2,
or T cells as detected by Abs to CD3e, respectively.
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Such observations indicate that melanocyte differentiation
antigen-based vaccination of mice can reproduce a condition
very reminiscent of progressive human vitiligo. We have
exploited this principle as a model to study precipitating
factors for vitiligo, a much needed development in this line of
research where successful mouse models are lacking.
In this study, the main objective has been to demonstrate
that HSP70, a stress protein more actively secreted by vitiligo
than control melanocytes (Kroll et al., 2005), can activate an
immune response to melanocytes in our in vivo gene gun
vaccination model of human vitiligo. In initial experiments
(data not shown), it became clear that high-dose vaccination
with DNA encoding melanocyte differentiation antigens
alone can introduce depigmenting lesions of the pelage
among vaccinated mice, consistent with earlier observations.
Given our interest in establishing a role for HSP70 in
autoimmune depigmentation within a mouse model of
human vitiligo, vector constructs were generated encoding
the human (and mouse) HSP70 molecules(s). Once intro-
duced into mice, the HSP70 molecule proved to be an
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Figure 4. Vaccination with HSP70 encoding vectors induces a humoral response to the protein. Sera from five mice were pooled and reacted with western
blots of proteins from transfected COS cells or purified stress proteins as indicated. Sera used were from mice vaccinated with plasmids encoding (a) TRP-2,
(b) empty vector control, (c) hHSP70, (d) hHSP70 and TRP-2, (e) mHSP70 and TRP-2, and (f) hHSP70 and TRP-2. Prominent reactivity to a 70 kDa protein was
observed only in sera from mice vaccinated in (combinations of) plasmids encoding human or mouse-derived HSP70. Such reactivity was not observed in mice
vaccinated with TRP-2-encoding plasmid or control plasmid alone; no reactivity to TRP-2 was observed in any of the pooled sera. In blot (f), the 70 kDa detected
protein was positively identified as HSP70. As a negative control, no reactivity to HSP60 was observed. The band of interest is highlighted by an arrowhead.
Note that COS cells express some HSP70 regardless of transfection. HSP60P and HSP70P: purified proteins and hHSP70, mHSP70 and hTRP-2: cos cells
transfected with plasmids encoding named proteins.
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Figure 5. Depigmentation is associated with a cytotoxic response to TRP-2-expressing melanocytes. For in vivo cytotoxicity assays, all mice were challenged
with an equal number of spleen cells loaded with an irrelevant peptide plus 1 mM CFSE (left peak P6, CFSElow), or a TRP-2-derived peptide and 8 mM CFSE (right
peak P7, CFSEhigh). Spleens from challenged mice are harvested after 18 hours and analyzed by FACS. Cytotoxicity was calculated from the relative area
underlying either peak, with loss of cells from the CFSEhigh peak ascribed to cytotoxic T cells targeting TRP-2180–188. Histograms are shown for representative
mice that were vaccinated with (a) hHSP70 alone or (b) hHSP70 and hTRP-2, 5 days before the in vivo cytotoxicity challenge.
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efficient instigator of depigmentation among treated mice in
two separate models assessed, when administered in
combination with suboptimal doses of 2.4mg DNA encoding
a target antigen of interest. At this concentration, TRP-2-
encoding plasmid alone did not induce significant depig-
mentation. The mechanism of gene gun vaccination has been
ascribed, in part, to direct introduction of the DNA into
Langerhans cells and DCs (Lauterbach et al., 2006). Given
the protein chaperoning function of stress proteins, any cell
upregulating expression of the TRP-2 and HSP70 genes can
become an efficient source of antigen to be subsequently
taken up and cross-presented by DCs, further contributing
to the antigenicity of this particular vaccine. In a pilot
experiment, results indicated that HSP70 can similarly
enhance gp100-induced depigmentation (data not shown).
HSP70 has caught attention in reference to autoimmune
vitiligo in the past (Kroll et al., 2005). In this regard, the stress
protein is of interest because it can be secreted by live cells.
Initial observations supported differential expression of the
stress protein among non-lesional and lesional skin of vitiligo
patients (unpublished observation). Stress proteins, in gen-
eral, and HSP70, in particular, are of interest as they protect
cells from undergoing apoptosis in crisis situations by
chaperoning proteins and peptides within the cell. Combined
with DCs activating properties, such as enhanced uptake of
antigens and enhanced expression of DC activation markers
in response to HSP70 exposure, the stress protein may be
responsible for translating stress into an autoimmune
response to melanocytes in vitiligo. This study strongly
supports this hypothesis. The data show that human as well
as mouse-derived HSP70 can accelerate an immune response
to melanocytes in mice. Interestingly, development of
depigmentation at sites distant from the original vaccination
site was restricted to the mice vaccinated with (combinations
of) mouse-derived HSP70. It should be noted that this
differential fact was observed under conditions where the
amount of antigen-encoding DNA was limiting (2.4 mg
weekly for 4 weeks) and that dorsal depigmentation has
been routinely observed in mice vaccinated with 4 mg of
target antigen-encoding DNA alone (unpublished observa-
tion). The restricting experimental conditions used here
highlight the superior depigmenting effect of mouse-derived
HSP, possibly explained by the biological function, rather
than the immunogenicity, of HSP70 carrying responsibility
for its immune activating properties.
Mice vaccinated with either human or mouse HSP70
elicited a humoral response to the protein with circulating
antibodies (Abs) readily detectable 3 months after vaccina-
tion (later time points not tested). By contrast, Abs to TRP-2
were never found in TRP-2-vaccinated mice. Although the
presence of Abs reactive with TRP-2 in vitiligo sera has been
reported (Okamoto et al., 1998), such Abs likely represent an
epiphenomenon that occurs when TRP-2 is spilled from dying
melanocytes. As the protein is contained in the melanosomal
compartment of living cells, Abs to TRP-2 are unlikely to
affect melanocyte viability or contribute to depigmentation.
Abs to mouse HSP70 are possibly a better ‘‘fit’’ for the
naturally expressed protein to enhance its uptake (and its
chaperoned proteins) by DCs, explaining why rapid depig-
mentation of the dorsal area was observed solely in mHSP70-
vaccinated mice.
Importantly, whereas depigmentation was observed in
mice with Ab titers to HSP70 outlasting progressive pelage
depigmentation, the development of vitiligo was associated
with a loss of melanocytes (Figure 3a), a re-distribution of
resident skin T cells (Figure 3b) and a cytotoxic T-cell
response to melanocytes as demonstrated by TRP-2180–188-
restricted responses during active depigmentation. These
findings are well aligned with observations previously
reported for human vitiligo skin (Le Poole et al., 1993a;
Das et al., 2001). Cytotoxic T-cell responses were not
detectable 3 months or even 6 weeks after vaccination by
either ELISA, ELISPOT (enzyme-linked immunosorbent spot),
cytotoxicity assays, or dimer staining followed by FACS
analysis (results not shown).
These data are best explained by HSP70 facilitating antigen
uptake by DCs, thereby facilitating the recruitment of CD4þ
and particularly CD8þ T cells toward the skin. A direct
cytolytic effect of HSP70-reactive Abs toward mouse melano-
cytes was less likely to contribute to pelage depigmentation, as
preliminary data indicated that pooled sera from HSP70-
vaccinated mice did not mediate complement-mediated lysis
of 4-TBP exposed, stressed mouse melanocytes, or melanoma
cells in vitro (data not shown). Several receptors for HSPs have
thus far been identified, including CD91, CD40, and TLR-2,
and TLR-4 (Sanchez-Perez et al., 2006). Among these
receptors, expression of CD91 was found to be abundant
among cells in close proximity to the epidermis and with
dendritic morphology in perilesional skin (data not shown).
Stress-induced overexpression of stress proteins, particularly
HSP70, which can be secreted by live cells and facilitates
immune responses by enhancing DC activation, can be a
relevant mechanism to explain how stress to the skin translates
into an immune response targeting melanocytes. Further
because HSP70 is overexpressed by cells in crisis, including
melanocytes (Bivik et al., 2007), it is well conceivable that
melanocytes become prime targets of the immune response
following stress, leading to the development of progressing
vitiligo lesions. In conclusion, the data provide support for the
concept that vitiligo is a T-cell-mediated autoimmune disease
that precipitates in response to stress.
MATERIALS AND METHODS
Cloning and sequencing of hTRP-2, hHSP70, and mHSP70
For hTRP-2 expression cloning, RNA was isolated from M14 human
melanoma cells (25). TRP-2 transcripts were amplified in the
presence of the following primers: 50-CACCATGAGCCCCC
TTTGGTGGGGGTTTC-30 (forward) and 50-CTAGGCTTCTTCTGTG
TATCTCTTG-30 (reverse). The CACC sequence in the upstream
primer allowed for directional TOPO cloning of the PCR product
into pcDNA3.1D/V5-His-TOPO (Invitrogen, Carlsbad, CA). Human
HSP70i was amplified from human primary keratinocyte RNA in the
presence of primers 50-ATGGCCGCGGCGATCG-30 (forward) and
50-CTAATCTACCTCAATGGTG-30 (reverse), and mouse HSP70A1A
was amplified from mouse skin tissue-derived RNA using primers
50-ATGGCAAGAACACGGCGATCGGCAT-30 (forward) and 50-CTAA
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TCCACCTCCTCGATGGTGGGTCC-30 (reverse). HSP70-encoding
genes were cloned into pcDNA3.1/CT-GFP-TOPO (Invitrogen).
Reverse transcription PCR conditions for all amplifications were as
follows: 5mg RNA was combined with 1 first strand reverse
transcription buffer in presence of 1mM each of dNTPs, 10mM DTT
(dithiothreitol), 3.3mM MgCl2, 25 ngml
1 oligodT primer and 200U
Supercript II reverse transcriptase at 42 1C, terminating the reaction
by heating to 70 1C. Ten percent of the reverse transcription reaction
was PCR amplified 1 PCR buffer, 2mM MgCl2, 400 mM each of
dNTPs, 0.8 mgml1 primers and 5U Taq polymerase. In the case of
hTRP-2, Taq polymerase was replaced by 2.5U AccuPrime enzyme
(Invirtrogen) and additives were replaced by 1 AccuPrime mix
(Invitrogen). PCR reactions were run for 40 cycles at 95 1C for
30 seconds, 58 1C for 30 seconds, and 72 1C for 100 seconds,
followed by 10minutes at 72 1C. PCR products were cloned into
the appropriate vectors according to the manufacturer’s instructions.
Four bacterial colonies from each cloning procedure were subjected
to restriction analysis, and a clone containing the gene in the correct
orientation was used for a MegaPrep endotoxin-free isolation
procedure (Qiagen, Valencia, CA) and verified by sequencing
through the Sequencing Core of Loyola University Medical Center.
Successful expression of all proteins encoded by eukaryotic
expression vectors included in vaccines, including hHSP70,
mHSP70, and TRP-2, was confirmed by western blotting of total
protein from transfected COS cells, followed by indirect alkaline
phosphatase immunostaining.
Western blotting
COS cells were transfected with individual plasmids encoding
human HSP70i, mouse HSp70A1A, and human TRP-2 using
lipofectamine reagent (Invitrogen) according to manufacturer’s
instructions. Total proteins were isolated after 48 hours, and protein
content was measured using Bio-Rad Protein Assay reagent (Bio-Rad,
Hercules, CA), for equal loading at 12.5mg for cellular proteins, or
5mg of purified HSP60 or HSP70 per slot onto a 10% polyacrylamide
minigel. After electrophoresis, separated proteins were transferred on
to Immobilon-P membrane (Millipore, Billerica, MA). The blots were
incubated with anti-HSP70 Ab (rabbit polyclonal Ab at 1:1,500 or
mouse mAb SPA-810 at 1:2,000; Assay Designs, Ann Arbor, MI),
anti-TRP-2 Ab (goat polyclonal Ab at 1:1,000; Santa Cruz
Biotechnology Inc., Santa Cruz, CA), or incubated with pooled sera
from five vaccinated mice as the primary Abs (1:100 each). After
washing, blots were reacted with alkaline phosphatase-conjugated
secondary Abs (goat anti-rabbit, rabbit anti-goat, or goat anti-mouse
at 1:1,000; Santa Cruz Biotechnology Inc.). Blots were developed
with 5-bromo-4-chloro-3-indolyl phosphate/Nitro blue tetrazolium
(Sigma-Aldrich, St Louis, MO) as the substrate.
Bullet preparation and gene gun vaccination
To prepare bullets, endotoxin-free plasmid DNA in desired
combinations was precipitated onto spermidine-coated gold beads
(Fluka Biochemika, Buchs, Switzerland and Sigma-Aldrich) in the
presence of 200mM CaCl2 (Sigma, St Louis, MO) and 10 volumes of
ethanol (Sigma). Washed beads were precipitated onto silicone
tubing (Bio-Rad) in a BioRad Tubing Prep Station (Bio-Rad). Bullets
were used within 10 days of preparation.
Two strains of mice (C57BL/6J from Jackson Labs, Bar Harbor,
ME, and 129S7 from Taconic, Hudson, NY) were included in
experiments. Group sizes were 5 or 10 mice per group as indicated
in the figure legends. All experiments were approved by Loyola
University Medical Center’s Institutional Animal Care and Use
Committee. Mice were prepared for weekly gene gun vaccination by
biweekly ventral hair removal with Nair (Church and Dwight Co.,
Princeton, NJ) and injections of ketamine (ketaject, IVX Animal
Health, St Joseph, MO) at 95mg kg1 and xylazine (IVX Animal
Health) at 5mg kg1, and vaccinated with 4.8 mg of DNA for four
consecutive weeks. By gene gun vaccination using the Helios Gene
Gun System (Bio-Rad), gold particles coated with DNA of interest
are released from silicon tubing cartridges under helium pressure at
maximum 300p.s.i. (pound per square inch), which allows for DNA
to directly enter the skin and nestle inside relevant cell types such as
DC, where the DNA can be expressed before and after migration to
draining lymph nodes to induce an immune response to antigens
encoded by the vaccine.
Evaluating depigmentation
Depigmentation was evaluated by scanning front and back of the mice
with a flatbed scanner under anesthesia, and subsequent image analysis
using Adobe Photoshop software (Adobe Systems Inc., San Jose, CA).
The percentage of depigmentation was calculated from the largest
evaluable area as the percentage of pixels among4150,000 evaluated
with a luminosity above the cutoff level set to include 95% of pixels for
untreated mice. Statistical analysis of data was performed by comparing
relevant groups by Student’s t-test using Excel software.
Immunohistology
At euthanasia, biopsies of mouse skin were embedded in OCT
compound (Sakura Finetek USA, Torrance, CA) and snap-frozen in
liquid nitrogen. A measure of 8 mm cryostat sections were fixed in
cold acetone and stored at 20 1C until use. Sections were stained
with polyclonal Abs D18 to TRP-2 (goat polyclonal; Santa Cruz
Biotechnology Inc.), C20 to S100 (Santa Cruz Biotechnology Inc.), or
biotinylated 1452C11 to CD3e (Armenian Hamster monoclonal;
Pharmingen, San Diego, CA) in an indirect immunoperoxidase
staining procedure essentially, as described previously (Le Poole
et al., 1993a, b). Qualitative evaluation of sections from each group
was performed by two independent investigators.
In vivo cytotoxicity assessment
For in vivo cytotoxicity, fresh spleen cells were harvested from
C57BL/6J mice, and separate batches were pulsed with relevant TRP-
2-derived, K(b)-restricted peptide 180–188 SVYDFFVWL (a kind gift
from Dr Ross Kedl, UCHSC (University of Colorado Health Sciences
Center), Denver, CO) and irrelevant HPV16E7-derived, D(b)-
restricted peptide 49–57 RAHYNIVTF (a kind gift from Dr Martin
Kast, USC, Los Angeles, CA), then pulsed with 8 and 0.5 mM carboxyl
fluorescein succimidyl ester (CFSE) (Invitrogen), respectively. La-
beled cells were periorbitally injected into mice of differentially
vaccinated mouse groups 5 days after a booster gene gun
vaccination. Eighteen hours after injection, mice were killed, and
samples representing 5,000 recovered irrelevantly pulsed spleen
cells were scanned using FACScanto equipment (BD Biosciences,
Sparks, MD). The FACScanto is a benchtop flow cytometer that
contains a 15mV argon-ion laser and a red diode laser, and has the
capability for detection of six fluorescent detection channels plus
right and forward angle scatter.
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